Literature DB >> 17031815

Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC).

Agnes B Baffoe-Bonnie1, Rick A Kittles, Elizabeth Gillanders, Liang Ou, Asha George, Christiane Robbins, Chiledum Ahaghotu, James Bennett, William Boykin, Gerald Hoke, Terry Mason, Curtis Pettaway, Srinivasan Vijayakumar, Sally Weinrich, Mary P Jones, Derek Gildea, Erica Riedesel, Julie Albertus, Tracy Moses, Erica Lockwood, Meghan Klaric, Mezbah Faruque, Charmaine Royal, Jeffrey M Trent, Kate Berg, Francis S Collins, Paulette M Furbert-Harris, Joan E Bailey-Wilson, Georgia M Dunston, Isaac Powell, John D Carpten.   

Abstract

BACKGROUND: The African American Hereditary Prostate Cancer (AAHPC) Study was designed to recruit families with early-onset disease fulfilling criteria of >or=4 affected.
METHODS: We present a approximately 10 cM genome-wide linkage (GWL) analysis on 77 families including 254 affected and 274 unaffected genotyped.
RESULTS: Linkage analysis revealed three chromosomal regions with GENEHUNTER multipoint HLOD scores >or=1.3 for all 77 families at 11q22, 17p11, and Xq21. One family yielded genome-wide significant evidence of linkage (LOD = 3.5) to the 17p11 region with seven other families >or=2.3 in this region. Twenty-nine families with no-male-to-male (MM) transmission gave a peak HLOD of 1.62 (alpha = 0.33) at the Xq21 locus. Two novel peaks >or=0.91 for the 16 families with '>6 affected' occurred at 2p21 and 22q12.
CONCLUSIONS: These chromosomal regions in the genome warrant further follow-up based on the hypothesis of multiple susceptibility genes with modest effects, or several major genes segregating in small subsets of families. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17031815     DOI: 10.1002/pros.20456

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.

Authors:  Yongquan Wang; Jianghua Wang; Li Zhang; Omer Faruk Karatas; Longjiang Shao; Yiqun Zhang; Patricia Castro; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2017-06-13       Impact factor: 12.701

2.  Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer.

Authors:  Kelvin A Moses; Heather Orom; Alicia Brasel; Jacquelyne Gaddy; Willie Underwood
Journal:  Urol Oncol       Date:  2016-05-06       Impact factor: 3.498

Review 3.  The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.

Authors:  Isaac J Powell
Journal:  Arch Esp Urol       Date:  2011-10       Impact factor: 0.436

Review 4.  Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.

Authors:  Timothy R Rebbeck
Journal:  Semin Radiat Oncol       Date:  2016-08-26       Impact factor: 5.934

Review 5.  Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood.

Authors:  Timothy R Rebbeck
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

6.  Brief report: Under-representation of African americans in autism genetic research: a rationale for inclusion of subjects representing diverse family structures.

Authors:  Claudia L Hilton; Robert T Fitzgerald; Kelley M Jackson; Rolanda A Maxim; Christopher C Bosworth; Paul T Shattuck; Daniel H Geschwind; John N Constantino
Journal:  J Autism Dev Disord       Date:  2010-05

7.  The Eastland Prostate Cancer Survey: instrument development and psychometric testing.

Authors:  Taryn Y Eastland; Barbara L Dancy
Journal:  J Cancer Educ       Date:  2013-03       Impact factor: 2.037

8.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

Review 9.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

10.  Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.

Authors:  Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Agnes B Baffoe-Bonnie; Asha George; Isaac Powell; Joan E Bailey-Wilson; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Maehle; Pal Moller; Ros Eeles; Douglas Easton; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Jianfeng Xu; Janet L Stanford; Bo Johanneson; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Daniel J Schaid; Ethan M Lange; Kathleen A Cooney; Teuvo L J Tammela; Johanna Schleutker; Thomas Paiss; Christiane Maier; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; William B Isaacs
Journal:  Hum Mol Genet       Date:  2007-05-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.